GET MORE FROM MEDICINES.
RxAnte delivers analytics-powered solutions and clinical services that enable health plans, care providers, and pharmaceutical manufacturers to realize more value from medicines.
-
Our mission is to improve how medicines are prescribed, taken, and paid for. We do things like:
Help health plans improve Medicare Part D and quality measures and avoid medical costs related to medication non-adherence.
Enable care providers to better understand and address barriers to their patients’ medication use.
Inform meaningful, evidence-driven discussions with pharmaceutical manufacturers and health plans about drug performance and contracting.
-
The no-obligation RxAnte Adherence Strategy Report is how top-performing Part D plans design their adherence programs.
Highly accurate performance forecasting. Know where you’ll land on the triple-weighted measures this year.
Program simulations. Learn how many interventions are needed to achieve your adherence goals.
Strategic advisory services. Our experts guide your program strategy.
-
Stars Tool: 2021 CMS Stars Data Now Available
Our interactive tool for health plans has been updated. See Star Ratings comparisons across medication measures and the correlation between them. Filters, sliders, and hover capabilities let you see what you need to succeed against rising cut points.
The Results
of Medicare Part D contract measures managed by RxAnte improve year-over-year
of lives in 5-Star MAPD plans under RxAnte management
lives under management
For Health Plans
Deploy our analytics-powered solutions to improve clinical quality, achieve medical cost savings, and better realize the value of medicines on your member populations.
Tell Me More
For Providers
Drive improvements in shared risk arrangements using our predictive analytics and direct-to-patient interventions to ensure patients’ adherence to their medicines.
Tell Me MoreOur Interventions
Deploy the right intervention mix across your population to achieve quality and cost objectives.
Tell Me More
Resources & Blog
More Resources06.22.21
by Tori Erxleben Rush, PharmD
Addressing the New Polypharmacy Display Measures
Blog Post
Polypharmacy is a familiar topic for many when discussing adherence and prescribing behavior. With the addition of three polypharmacy-related display measures for the 2022 CMS quality measure performance year, we turned to Tori Erxleben Rush, PharmD, RxAnte Product Director, to learn more about the display measures and their significance to health plans and their members .
06.03.21
Case Study: Improving pharmacy quality measures in a DSNP contract
Whitepaper
See how one health plan client and RxAnte took steps to leverage their existing quality program and adopt new strategies within their DSNP population to scale outreach efforts and target a greater percentage of their high-value membership.
05.28.21
Expanding the Scope of Adherence Interventions with Value of Future Adherence™
Blog Post
When considering the value of medication adherence, we have typically spoken of improving this aspect of healthcare quality in the context of CMS Stars adherence measures; however, research has also illustrated savings in total cost of care through improved medication adherence. Discover how RxAnte's Value of Future Adherence software is providing plans another way to view their members' medication use.
Request More Info
Think RxAnte might be right for your organization? Let’s get in touch.
Let's Get StartedUpcoming Events
More Resources06.22.21
by Tori Erxleben Rush, PharmD
Addressing the New Polypharmacy Display Measures
Blog Post
Polypharmacy is a familiar topic for many when discussing adherence and prescribing behavior. With the addition of three polypharmacy-related display measures for the 2022 CMS quality measure performance year, we turned to Tori Erxleben Rush, PharmD, RxAnte Product Director, to learn more about the display measures and their significance to health plans and their members .
06.03.21
Case Study: Improving pharmacy quality measures in a DSNP contract
Whitepaper
See how one health plan client and RxAnte took steps to leverage their existing quality program and adopt new strategies within their DSNP population to scale outreach efforts and target a greater percentage of their high-value membership.
05.28.21
Expanding the Scope of Adherence Interventions with Value of Future Adherence™
Blog Post
When considering the value of medication adherence, we have typically spoken of improving this aspect of healthcare quality in the context of CMS Stars adherence measures; however, research has also illustrated savings in total cost of care through improved medication adherence. Discover how RxAnte's Value of Future Adherence software is providing plans another way to view their members' medication use.